News

Published on 1 Nov 2024 on Investing.com

Insider Activity: Thursday's Top Buys and Sells in US Stocks By Investing.com


Article preview image

Insider Activity: Thursday's Top Buys and Sells in US Stocks

NASDAQ.SIRI price evolution
NYSE.PFE price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Insider Activity: Thursday's Top Buys and Sells in US Stocks By Investing.com

Insider Activity: Thursday's Top Buys and Sells in US Stocks

Investing.com 1 Nov 2024

Pfizer Earnings: Maintaining Our Valuation as Management Pressed for Evidence of...

Pfizer PFE reported stronger third-quarter results than we anticipated, largely due to significan...

Morningstar 29 Oct 2024

Pfizer Q3 Earnings: Revenue And Profit Beat On Heightened Demand For Paxlovid,...

On Tuesday, Pfizer Inc. (NYSE:PFE) reported third-quarter adjusted EPS of $1.06, a turnaround fro...

Benzinga · via Yahoo Finance 29 Oct 2024

Pfizer, Alphabet And 3 Stocks To Watch Heading Into Tuesday - Pfizer (NYSE:PFE)

With U.S. stock futures trading mixed this morning on Tuesday, some of the stocks that may grab i...

Benzinga 29 Oct 2024

Pfizer management looks to show turnaround as Starboard looms

Investors and analysts said they want to see improved profitability following the company's billi...

Reuters 28 Oct 2024

Pfizer’s Activist Battle Might Fizzle—but Its Stock Probably Won’t

The pharmaceutical company’s stock is relatively cheap, representing an opportunity for patient...

The Wall Street Journal 26 Oct 2024

FDA Approves Pfizer's Respiratory Syncytial Virus Vaccine Abrysvo For Adults...

On Tuesday, the FDA approved Pfizer Inc’s (NYSE:PFE) Abrysvo (Respiratory Syncytial Virus Vaccine...

Benzinga · via Yahoo Finance 23 Oct 2024

Starboard Value CEO says Pfizer's board should hold management accountable

Smith is also Starboard's chief investment officer. Starboard has built a $1 billion position in...

Reuters 22 Oct 2024

Activist Investor Starboard Slams Pfizer for Underperforming R&D And Overpaying...

(NYSE:PFE), holding the pharmaceutical giant’s management accountable for failing to deliver on i...

Benzinga · via AOL 22 Oct 2024

Pfizer Inc. (PFE): Among the Worst Performing Blue Chip Stocks in 2024

We recently compiled a list of the 10 Worst Performing Blue Chip Stocks in 2024. In this article,...

Insider Monkey · via Yahoo Finance 21 Oct 2024